The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
<p>Telomerase is expressed in the majority (>85%) of tumours but not in differentiated normal tissue. This enzyme catalyses the elongation of telomeres – a process critical for continued cell proliferation. Telomerase is a potential novel target for molecularly-targeted radiotherapy (mR...
Auteur principal: | Jackson, M |
---|---|
Autres auteurs: | Vallis, K |
Format: | Thèse |
Langue: | English |
Publié: |
2013
|
Sujets: |
Documents similaires
-
Selective targeting of homologous recombination deficiency
par: Zimmer, J
Publié: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
par: Albukhari, A
Publié: (2014) -
Targeting EGFR signalling pathway in triple negative breast cancer
par: Albukhari, A
Publié: (2014) -
Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
par: Potter, M
Publié: (2014) -
Radiopharmaceutical Validation for Clinical Use
par: Charles A. Kunos, et autres
Publié: (2021-03-01)